Skip to main content
. 2020 Feb;9(1):3–9. doi: 10.21037/tau.2019.08.03

Table 2. Stricture and treatment characteristics.

Parameter No failure Failure P
Location of stricture, n (%) 0.3
   Distal bulbar urethra 5 [9] 6 [22]
   Membranous urethra 14 [26] 7 [26]
   Proximal bulbar urethra 34 [64] 14 [52]
Stricture length, cm* 1 [0.5–1] 0.7 [0.5–1.5] 0.9
Stricture stage, n (%) 0.4
   1 2 [4] 0
   2 13 [25] 5 [19]
   3 37 [71] 22 [81]
Second stricture, n (%) 0.2
   Bladder neck contracture 3 [6] 1 [4]
   Membranous urethra 0 1 [4]
   Pendulous urethra 0 1 [4]
Any prior treatment, n (%) 36 [68] 25 [93] 0.01
   Number of prior treatments 1 [0–3] 4 [1–6] 0.0003
Prior dilation 18 [34] 16 [59] 0.04
   Number of previous dilations 0 [0–1] 1 [0–5] 0.005
Prior DVIU 10 [19] 9 [33] 0.2
   Number of previous DVIUs 0 [0–0] 0 [0–1] 0.2
Prior urethroplasty, n (%) 27 [51] 21 [78] 0.03
   Number of prior urethroplasties 1 [0–1] 1 [1–2] 0.004
   With prior endoscopic interventions, n (%) 14 [26] 13 [48] 0.08
Time from symptoms to balloon dilation, yrs 5.4 [1.0–10] 3.8 [0.5–32] 0.9
Complications of balloon dilation, n (%) 2 [4] 4 [15] 0.2
   Infection 0 1 [4] 0.3
   Urinary retention 2 [4] 3 [11] 0.3
Multiple balloon dilations 3 [6] 4 [15] 0.2
Self-catheterization post-procedure, n (%) 4 [8] 4 [15] 0.4

Continuous variables are presented as medians with interquartile ranges in square parentheses. *, available for 56 patients; , unavailable for 1 patient; , refers to the first balloon dilation, for patients who underwent multiple. DVIU, direct vision internal urethrotomy. IPSS, International Prostate Symptom Score.